Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Hobbs, FDR"'
Autor:
Montgomery H; Department of Medicine, University College London, London, UK., Hobbs FDR; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK., Padilla F; Centro de Investigación en Cardiología y Metabolismo, Guadalajara, Jalisco, Mexico., Arbetter D; Biometrics, Vaccines and Immune Therapies, BioPharmaceuticals Research and Development, AstraZeneca, Boston, MA, USA., Templeton A; Biometrics, Vaccines and Immune Therapies, BioPharmaceuticals Research and Development, AstraZeneca, Cambridge, UK., Seegobin S; Biometrics, Vaccines and Immune Therapies, BioPharmaceuticals Research and Development, AstraZeneca, Cambridge, UK., Kim K; ARK Clinical Research, Long Beach, CA, USA., Campos JAS; Köhler & Milstein Research/Hospital Agustín O'Horán, Mérida, Yucatán, Mexico., Arends RH; Clinical Pharmacology and Safety Sciences, BioPharmaceuticals Research and Development, AstraZeneca, Cambridge, UK., Brodek BH; Development Operations, BioPharmaceuticals Research and Development, AstraZeneca, Gaithersburg, MD, USA., Brooks D; Patient Safety, Chief Medical Office, BioPharmaceuticals Research and Development, AstraZeneca, Gaithersburg, MD, USA., Garbes P; Clinical Pharmacology and Quantitative Pharmacology, Clinical Development, Vaccines and Immune Therapies, BioPharmaceuticals Research and Development, AstraZeneca, Gaithersburg, MD, USA., Jimenez J; Clinical Pharmacology and Quantitative Pharmacology, Clinical Development, Vaccines and Immune Therapies, BioPharmaceuticals Research and Development, AstraZeneca, Gaithersburg, MD, USA., Koh GCKW; Clinical Development, Vaccines and Immune Therapies, BioPharmaceuticals Research and Development, AstraZeneca, Cambridge, UK., Padilla KW; Clinical Development, Late-stage Development, Vaccines and Immune Therapies, BioPharmaceuticals Research and Development, AstraZeneca, Durham, NC, USA., Streicher K; Translational Medicine, Vaccines and Immune Therapies, BioPharmaceuticals Research and Development, AstraZeneca, Gaithersburg, MD, USA., Viani RM; Clinical Pharmacology and Quantitative Pharmacology, Clinical Development, Vaccines and Immune Therapies, BioPharmaceuticals Research and Development, AstraZeneca, Gaithersburg, MD, USA., Alagappan V; Late-stage Development, Respiratory and Immunology, BioPharmaceuticals Research and Development, AstraZeneca, Gaithersburg, MD, USA., Pangalos MN; Vaccines and Immune Therapies, BioPharmaceuticals Research and Development, AstraZeneca, Cambridge, UK., Esser MT; Vaccines and Immune Therapies, BioPharmaceuticals Research and Development, AstraZeneca, Gaithersburg, MD, USA. Electronic address: mark.esser@astrazeneca.com.
Publikováno v:
The Lancet. Respiratory medicine [Lancet Respir Med] 2022 Oct; Vol. 10 (10), pp. 985-996. Date of Electronic Publication: 2022 Jun 07.
Autor:
Cake C; Health Data Research UK, Wellcome Trust, Gibbs Building, 215 Euston Road, London, NW1 2BE, UK. Caroline.cake@hdruk.ac.uk., Ogburn E; Nuffield Department of Primary Care Health Sciences, University of Oxford, Gibson Building 1st Floor, Radcliffe Observatory Quarter, Woodstock Road, Oxford, OX2 6GG, UK., Pinches H; NHS DigiTrials, Skipton House, 80 London Rd, Elephant and Castle, London, UK., Coleman G; NHS Digital, Skipton House, 80 London Rd, Elephant and Castle, London, SE1 6LH, UK., Seymour D; Health Data Research UK, Wellcome Trust, Gibbs Building, 215 Euston Road, London, NW1 2BE, UK., Woodard F; NHS Digital, Skipton House, 80 London Rd, Elephant and Castle, London, SE1 6LH, UK., Manohar S; Health Data Research UK, Wellcome Trust, Gibbs Building, 215 Euston Road, London, NW1 2BE, UK., Monsur M; DHSC, Department for Health and Social Care, 39 Victoria St, Westminster, London, SW1H 0EU, UK., Landray M; HDR UK Oxford, Big Data Institute, Nuffield Department of Population Health, University of Oxford, Oxford, OX3 7LF, UK., Dalton G; NHS Digital, Skipton House, 80 London Rd, Elephant and Castle, London, SE1 6LH, UK., Morris AD; Health Data Research UK, Wellcome Trust, Gibbs Building, 215 Euston Road, London, NW1 2BE, UK., Chinnery PF; Department of Clinical Neuroscience & Medical Research Council Mitochondrial Biology Unit, School of Clinical Medicine, University of Cambridge, Cambridge, CB2 0QQ, UK., Hobbs FDR; Nuffield Department of Primary Care Health Sciences, University of Oxford, Gibson Building 1st Floor, Radcliffe Observatory Quarter, Woodstock Road, Oxford, OX2 6GG, UK., Butler C; Nuffield Department of Primary Care Health Sciences, University of Oxford, Gibson Building 1st Floor, Radcliffe Observatory Quarter, Woodstock Road, Oxford, OX2 6GG, UK.
Publikováno v:
Trials [Trials] 2022 Jan 20; Vol. 23 (1), pp. 62. Date of Electronic Publication: 2022 Jan 20.
Autor:
Yu LM; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK., Bafadhel M; Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK., Dorward J; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK; Centre for the AIDS Programme of Research in South Africa, University of KwaZulu-Natal, Durban, South Africa., Hayward G; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK., Saville BR; Berry Consultants, Austin, TX, USA; Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, TN, USA., Gbinigie O; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK., Van Hecke O; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK., Ogburn E; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK., Evans PH; College of Medicine and Health, University of Exeter, Exeter, UK; National Institute for Health Research Clinical Research Network, National Institute for Health Research, London, UK., Thomas NPB; National Institute for Health Research Clinical Research Network, National Institute for Health Research, London, UK; Royal College of General Practitioners, London, UK., Patel MG; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK., Richards D; Oxford Clinical Trials Research Unit, Botnar Research Centre, University of Oxford, Oxford, UK., Berry N; Berry Consultants, Austin, TX, USA., Detry MA; Berry Consultants, Austin, TX, USA., Saunders C; Berry Consultants, Austin, TX, USA., Fitzgerald M; Berry Consultants, Austin, TX, USA., Harris V; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK., Shanyinde M; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK., de Lusignan S; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK., Andersson MI; Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK., Barnes PJ; National Heart and Lung Institute, Imperial College, London, UK., Russell REK; Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK., Nicolau DV Jr; Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK; UQ Centre for Clinical Research, University of Queensland, Brisbane, QLD, Australia., Ramakrishnan S; National Institute for Health Research Oxford Biomedical Research Centre, Oxford, UK., Hobbs FDR; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK. Electronic address: richard.hobbs@phc.ox.ac.uk., Butler CC; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK. Electronic address: christopher.butler@phc.ox.ac.uk.
Publikováno v:
Lancet (London, England) [Lancet] 2021 Sep 04; Vol. 398 (10303), pp. 843-855. Date of Electronic Publication: 2021 Aug 10.
Autor:
Butler CC; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK. Electronic address: christopher.butler@phc.ox.ac.uk., Yu LM; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK., Dorward J; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK; Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, Durban, South Africa., Gbinigie O; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK., Hayward G; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK., Saville BR; Berry Consultants, Austin, TX, USA; Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, TN, USA., Van Hecke O; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK., Berry N; Berry Consultants, Austin, TX, USA., Detry MA; Berry Consultants, Austin, TX, USA., Saunders C; Berry Consultants, Austin, TX, USA., Fitzgerald M; Berry Consultants, Austin, TX, USA., Harris V; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK., Djukanovic R; Clinical and Experimental Science, National Institute for Health Research (NIHR) Southampton Biomedical Research Centre, Faculty of Medicine, University of Southampton, Southampton, UK., Gadola S; Rheumatology and Pain Medicine, Bethesda Hospital, Basel, Switzerland., Kirkpatrick J; Independent Researcher, Glatton, UK., de Lusignan S; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK., Ogburn E; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK., Evans PH; College of Medicine and Health, University of Exeter, Exeter, UK; NIHR Clinical Research Network, NIHR, London, UK., Thomas NPB; NIHR Clinical Research Network, NIHR, London, UK; Royal College of General Practitioners, London, UK., Patel MG; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK; School of Pharmacy and Medical Sciences, University of Bradford, Bradford, UK., Hobbs FDR; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
Publikováno v:
The Lancet. Respiratory medicine [Lancet Respir Med] 2021 Sep; Vol. 9 (9), pp. 1010-1020. Date of Electronic Publication: 2021 Jul 27.
Autor:
Group, PRINCIPLE Trial Collaborative, Butler, CC, Dorward, J, Yu, L-M, Gbinigie, O, Hayward, G, Saville, BR, Van Hecke, O, Berry, N, Detry, M, Saunders, C, Fitzgerald, M, Harris, V, Patel, MG, De Lusignan, S, Ogburn, E, Evans, PH, Thomas, NPB, Hobbs, FDR
Publikováno v:
Lancet (London, England)
© 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license Background: Azithromycin, an antibiotic with potential antiviral and anti-inflammatory properties, has been used to treat COVID-19, but evide
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7790f19113afd4aa8cb3a310f6381def
http://sro.sussex.ac.uk/id/eprint/106114/1/1-s2.0-S014067362100461X-main.pdf
http://sro.sussex.ac.uk/id/eprint/106114/1/1-s2.0-S014067362100461X-main.pdf
Autor:
de Lusignan, S, Lopez Bernal, J, Byford, R, Amirthalingam, G, Ferreira, F, Akinyemi, O, Andrews, N, Campbell, H, Dabrera, G, Deeks, A, Elliot, AJ, Krajenbrink, E, Liyanage, H, McGagh, D, Okusi, C, Parimalanathan, V, Ramsay, M, Smith, G, Tripathy, M, Williams, J, Victor, W, Zambon, M, Howsam, G, Nicholson, BD, Tzortziou Brown, V, Butler, CC, Joy, M, Hobbs, FDR
Publikováno v:
JMIR Public Health and Surveillance, Vol 7, Iss 2, p e24341 (2021)
JMIR Public Health and Surveillance
JMIR Public Health and Surveillance
Background The Oxford–Royal College of General Practitioners (RCGP) Research and Surveillance Centre (RSC) and Public Health England (PHE) are commencing their 54th season of collaboration at a time when SARS-CoV-2 infections are likely to be cocir